| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Short Communication |
Department of Veterinary and Biomedical Sciences and Nebraska Center for Virology, University of Nebraska-Lincoln (UNL), E126 Beadle Center, 1901 Vine Street, Lincoln, NE 68588-0666, USA
Correspondence
Asit K. Pattnaik
apattnaik2{at}unl.edu
 |
ABSTRACT |
|---|
 TOP ABSTRACT MAIN TEXTREFERENCES |
|---|
|
MAIN TEXT |
|---|
|
TOPABSTRACTMAIN TEXTREFERENCES |
|---|
9·6 kb RNA genome is translated to produce a polyprotein, which is processed proteolytically to generate the mature structural and non-structural (NS) proteins (Major & Feinstone, 1997
). The NS proteins are involved in viral genome replication, whereas the structural proteins participate in virion assembly and release (Bartenschlager & Lohmann, 2000; Rosenberg, 2001). Development of cell lines supporting replication of subgenomic replicons of HCV has revealed that adaptive mutations within the NS proteins are required for efficient replication of the replicons derived from genotype 1a and 1b genomes (Lohmann et al., 1999; Blight et al., 2000, 2003; Krieger et al., 2001; Yi & Lemon, 2004), although a similarly constructed replicon derived from a genotype 2a virus replicates efficiently with few or no adaptive mutations (Kato et al., 2003).
The NS5A protein is multifunctional. It contains an interferon sensitivity-determining region (ISDR) spanning aa 237–276 and may play a role in resistance to alpha interferon (Polyak et al., 1999). It contains an amphipathic 
-helix and a zinc-binding domain at the amino terminus, which are required for replication (Brass et al., 2002; Elazar et al., 2003; Tellinghuisen et al., 2004, 2005). In addition, the phosphorylation pattern of NS5A plays an important role in HCV genome replication (Evans et al., 2004b; Appel et al., 2005). It also interacts with a multitude of cellular proteins and alters the host cells to support viral RNA replication (Gale et al., 1998; Chung et al., 2000; Park et al., 2002; Evans et al., 2004a; Gao et al., 2004).
Transposon-mediated insertion mutagenesis (Goryshin & Reznikoff, 1998) is a powerful tool that allows insertion of short peptides into proteins encoded in cloned DNA to evaluate permissive sites in the protein. It can also be used to assess regions of the protein that are dispensable for its functions. In the present study, we used an Ez-Tn5 In-Frame Linker Insertion kit (Epicentre Biotechnologies) to introduce 57 bp in-frame insertions (corresponding to 19 aa in the protein) randomly into a plasmid encoding the NS5A protein. As the amphipathic -helix and the zinc-binding domain, which are required for replication, are located in the amino-terminal region, this region of the protein was excluded for insertion mutagenesis. We took advantage of the presence of a unique MluI site (corresponding to aa 92 in NS5A) for subsequent manipulation of the NS5A coding region. To facilitate subcloning of NS5A, an MluI site was engineered between aa 431 and 432 in NS5A (Fig. 1a) within the parental subgenomic replicon Con1S/G-Neo (Blight et al., 2000), henceforth referred to as Con1. This manipulation, which resulted in insertion of two residues (Thr and Arg) in NS5A at this position, did not affect colony-forming ability of the new replicon, Con1-MluI (Fig. 1b). Subsequently, the entire NS5A coding region of the new replicon was subcloned into the pGEM3 vector and used as template for transposon-mediated insertion mutagenesis as described previously (Das & Pattnaik, 2005). A panel of mutants with an insertion between residues 92 and 431 of NS5A was identified (Fig. 1a) and subcloned individually into the subgenomic replicon Con1-MluI.
|
) for 3 weeks. As shown in Fig. 1(b)
, insertion of 19 aa within the amino-terminal region of the NS5A protein (residues 96–227) and within residues 327–339 was lethal for replication. However, G418-resistant cell colonies, indicative of replication, could be generated by replicons encoding NS5A proteins with insertions at the carboxy-terminal region (residues 349–417), as well as the central region of the molecule (residues 240–314) spanning the ISDR (Fig. 1b), albeit with different efficiencies.
The observation that replicons with NS5A proteins containing insertions within the central region of the molecule spanning the ISDR could establish G418-resistant cell colonies is interesting. This contrasts with studies reported recently (Moradpour et al., 2004) identifying only two sites near the carboxy terminus that are permissible for insertion: one after residue 384 and the other after residue 418. It is possible that analysis of only 14 individual drug-resistant cell colonies from cells electroporated with a pool of insertion mutant-bearing replicons may have led to detection of only the mutant replicons with significantly higher efficiency of colony formation (Moradpour et al., 2004). This interpretation is compatible with our observation that insertions at the carboxy-terminal region of NS5A result in much higher efficiency of colony formation compared with that resulting from insertions in the central region.
RT-PCR analyses of RNA from various replicon-bearing cells maintained for at least 16 weeks in the presence of the drug showed that the products generated with RNA obtained from various mutant replicon-bearing cells were predictably larger than an expected product of 645 bp from the parental replicon-bearing cells (Fig. 1c), indicating that insertions were present in the replicons. Western blot analysis (Fig. 1d) of total cell extracts from mutant replicon-bearing cells also detected NS5A proteins that were slightly larger than NS5A obtained from the parental replicon-containing cells. It should be noted that NS5A generated from the TIM396 replicon possessed a slightly reduced electrophoretic mobility compared with the other insertion mutants. The reason(s) for this is not clear, but it could be due to hyperphosphorylation or other modification of this protein.
As we were able to generate replicons containing mutant NS5A with small (19 aa) insertions at several different sites in NS5A, we examined whether insertion of enhanced green fluorescent protein (eGFP) at these sites would also be tolerated. By using the unique NotI site present within the insertion sequences, we inserted full-length eGFP sequences in-frame with the NS5A protein in various replicons. Replicons with eGFP insertions within ISDR (TIM240-eGFP and TIM271-eGFP) were, in general, less efficient at establishing G418-resistant cell colonies than replicons (TIM349-eGFP, TIM389-eGFP, TIM396-eGFP, TIM410-eGFP and TIM417-eGFP) with insertions at the carboxy-terminal region of NS5A (Fig. 2a). Furthermore, replicons with insertions of eGFP were five- to 15-fold less efficient at establishing drug-resistant cells than the corresponding replicons with insertions of 19 aa. Although the majority of the sites tolerated insertion of eGFP, such insertion at site 314 was lethal. This site, at which a small insertion (19 aa) led to a viable replicon (TIM314), is in close proximity to several other sites spanning residues 327–348, where the small insertions were also lethal. It is possible that this region may be involved in specific interaction with a cellular or viral component necessary for replication. Insertion of eGFP at residue 314 may have blocked this interaction due to steric hindrance, resulting in a lethal phenotype.
|
). The epifluorescence pattern is punctate and perinuclear and is characteristically similar to the distribution of NS5A protein in cells supporting subgenomic HCV replication (El-Hage & Luo, 2003; Shi et al., 2003; Moradpour et al., 2004). To confirm that the eGFP signal observed in these cells was due to the NS5A–eGFP fusion protein, cell extracts from the cells were examined for the presence of the fusion protein by Western blot analyses. Results showed that both anti-NS5A antibody (Fig. 2c) and anti-eGFP antibody (Fig. 2d) detected a protein with a molecular mass of 84 kDa, the predicted size of the NS5A–eGFP fusion protein, in cells harbouring these replicons. Taken together, the results demonstrate that the epifluorescence observed in cells bearing these replicons is due to the NS5A–eGFP protein and suggest that the fusion protein is processed appropriately and is stable.
As insertions at several sites in NS5A were permissible, we examined whether these regions of the protein could be deleted without affecting its function in replication. Accordingly, we generated a series of deletion mutants (Fig. 3a) by taking advantage of the unique NotI site present in the insertion mutants. Although the replicons encoding the deletion mutants established drug-resistant cell colonies, their efficiency of colony formation was significantly lower (Fig. 3a) than that of the parental replicon or insertion-mutant replicons. Mutant replicons from which residues 240–417 or 271–417 of NS5A were deleted were non-functional in replication. Western blot analysis (Fig. 3b) of cell extracts from four deletion-mutant replicon-bearing cells revealed the presence of deleted NS5A proteins, although some deletion mutants possessed anomalous electrophoretic mobility, which could be due to the extent of phosphorylation of the proteins. RT-PCR analysis (data not shown) of RNA from the cells bearing these replicons and subsequent sequencing of the products confirmed that each of the mutant replicons still retained the introduced deletions.
|
; Chung et al., 2000; Park et al., 2002; Waris et al., 2003; Evans et al., 2004a; Gao et al., 2004) that may be necessary for replication. In addition, an amphipathic -helix and a zinc-binding site located at the amino terminus are required for replication (Brass et al., 2002; Elazar et al., 2003; Tellinghuisen et al., 2004, 2005). The amino-terminal region of the protein, spanning residues 1–213 (domain I; Tellinghuisen et al., 2004), is suggested to be globular and is proposed to be involved in homodimer formation for interaction with the membrane during replication (Tellinghuisen et al., 2005). Insertions within this domain may affect dimer formation and thereby inhibit the replication functions of the protein. In contrast, the central region, spanning residues 240–314 [which include part of the low-complexity sequence I (LCS I) and part of domain II; Tellinghuisen et al., 2004], and the carboxy-terminal region, spanning residues 349–417 (which include part of LCS II and part of domain III; Tellinghuisen et al., 2004), may be flexible and can accept insertions without adversely affecting the replication functions of NS5A. In this regard, it is interesting to note that adaptive mutations resulting in deletion of the ISDR (Blight et al., 2000) and the carboxy-terminal sequences (residues 399–441) have been demonstrated (Zhu et al., 2003). Our results with mutants containing insertions between residues 349 and 417 suggest that this region of NS5A may not possess important domains involved in replication. This interpretation is supported by our observation that deletion of residues 349–410 of NS5A did not abrogate replication functions of the protein.
In conclusion, our studies reported here demonstrate that the region spanning the ISDR, as well as the carboxy-terminal region of NS5A, can tolerate insertion of eGFP, whereas the amino terminus of the protein cannot tolerate even small insertions. Furthermore, deletions in the region spanning the ISDR and also in the carboxy-terminal regions of NS5A led to proteins that were functional in replication, albeit with reduced activity. With the recent establishment of full-length cDNA clones of the viral genome that produce infectious HCV in cultured cells (Lindenbach et al., 2005; Wakita et al., 2005; Zhong et al., 2005), it will be very useful to incorporate eGFP into the NS5A protein and examine replication of the virus by live-cell imaging. In addition, the panel of non-functional NS5A insertion mutants that we have generated will be useful in studies to address the role of specific cellular and viral protein interactions with the NS5A protein that mediate viral RNA replication.
|
ACKNOWLEDGEMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTMAIN TEXTREFERENCES |
|---|
Bartenschlager, R. & Lohmann, V. (2000). Replication of hepatitis C virus. J Gen Virol 81, 1631–1648.
Blight, K. J., Kolykhalov, A. A. & Rice, C. M. (2000). Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972–1974.
Blight, K. J., McKeating, J. A., Marcotrigiano, J. & Rice, C. M. (2003). Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77, 3181–3190.
Brass, V., Bieck, E., Montserret, R., Wölk, B., Hellings, J. A., Blum, H. E., Penin, F. & Moradpour, D. (2002). An amino-terminal amphipathic -helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 277, 8130–8139.
Chung, K. M., Lee, J., Kim, J.-E., Song, O.-K., Cho, S., Lim, J., Seedorf, M., Hahm, B. & Jang, S. K. (2000). Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin 
3. J Virol 74, 5233–5241.
Das, S. C. & Pattnaik, A. K. (2005). Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles. J Virol 79, 8101–8112.
Elazar, M., Cheong, K. H., Liu, P., Greenberg, H. B., Rice, C. M. & Glenn, J. S. (2003). Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol 77, 6055–6061.
El-Hage, N. & Luo, G. (2003). Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol 84, 2761–2769.
Evans, M. J., Rice, C. M. & Goff, S. P. (2004a). Genetic interactions between hepatitis C virus replicons. J Virol 78, 12085–12089.
Evans, M. J., Rice, C. M. & Goff, S. P. (2004b). Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A 101, 13038–13043.
Gale, M., Jr, Blakely, C. M., Kwieciszewski, B. & 7 other authors (1998). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18, 5208–5218.
Gao, L., Aizaki, H., He, J.-W. & Lai, M. M. C. (2004). Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 78, 3480–3488.
Goryshin, I. Y. & Reznikoff, W. S. (1998). Tn5 in vitro transposition. J Biol Chem 273, 7367–7374.
Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M. & Wakita, T. (2003). Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808–1817.[CrossRef][Medline]
Krieger, N., Lohmann, V. & Bartenschlager, R. (2001). Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75, 4614–4624.
Lindenbach, B. D., Evans, M. J., Syder, A. J. & 8 other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623–626.
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L. & Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113.
Major, M. E. & Feinstone, S. M. (1997). The molecular virology of hepatitis C. Hepatology 25, 1527–1538.[CrossRef][Medline]
Moradpour, D., Evans, M. J., Gosert, R., Yuan, Z., Blum, H. E., Goff, S. P., Lindenbach, B. D. & Rice, C. M. (2004). Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 78, 7400–7409.
Park, K.-J., Choi, S.-H., Lee, S. Y., Hwang, S. B. & Lai, M. M. C. (2002). Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor -stimulated nuclear factor 
B activation. J Biol Chem 277, 13122–13128.
Polyak, S. J., Paschal, D. M., McArdle, S., Gale, M. J., Jr, Moradpour, D. & Gretch, D. R. (1999). Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29, 1262–1271.[CrossRef][Medline]
Rosenberg, S. (2001). Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 313, 451–464.[CrossRef][Medline]
Shi, S. T., Lee, K.-J., Aizaki, H., Hwang, S. B. & Lai, M. M. C. (2003). Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol 77, 4160–4168.
Tellinghuisen, T. L., Marcotrigiano, J., Gorbalenya, A. E. & Rice, C. M. (2004). The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 279, 48576–48587.
Tellinghuisen, T. L., Marcotrigiano, J. & Rice, C. M. (2005). Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435, 374–379.[CrossRef][Medline]
Wakita, T., Pietschmann, T., Kato, T. & 9 other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791–796.[CrossRef][Medline]
Waris, G., Livolsi, A., Imbert, V., Peyron, J.-F. & Siddiqui, A. (2003). Hepatitis C virus NS5A and subgenomic replicon activate NF-B via tyrosine phosphorylation of IB and its degradation by calpain protease. J Biol Chem 278, 40778–40787.
Yi, M. & Lemon, S. M. (2004). Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol 78, 7904–7915.
Zhong, J., Gastaminza, P., Cheng, G. & 7 other authors (2005). Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102, 9294–9299.
Zhu, Q., Guo, J.-T. & Seeger, C. (2003). Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 77, 9204–9210.
Received 4 August 2005;
accepted 4 November 2005.
This article has been cited by other articles:
|
|
 |
|
  T. L. Tellinghuisen, K. L. Foss, J. C. Treadaway, and C. M. Rice Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein J. Virol., February 1, 2008; 82(3): 1073 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Tellinghuisen, M. J. Evans, T. von Hahn, S. You, and C. M. Rice Studying Hepatitis C Virus: Making the Best of a Bad Virus J. Virol., September 1, 2007; 81(17): 8853 - 8867. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Torres-Puente, J. M. Cuevas, N. Jimenez-Hernandez, M. A. Bracho, I. Garcia-Robles, F. Carnicer, J. del Olmo, E. Ortega, A. Moya, and F. Gonzalez-Candelas Contribution of insertions and deletions to the variability of hepatitis C virus populations J. Gen. Virol., August 1, 2007; 88(8): 2198 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Jones, S. N. Gretton, J. McLauchlan, and P. Targett-Adams Mobility analysis of an NS5A-GFP fusion protein in cells actively replicating hepatitis C virus subgenomic RNA J. Gen. Virol., February 1, 2007; 88(2): 470 - 475. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
